Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective

This article seeks to review the latest evidence with a view to explaining possible pharmacotherapies for the cardiovascular complications of COVID-19 including acute coronary syndrome, heart failure, myocarditis, arrhythmias, and venous thromboembolism, as well as possible interactions between these medications and those currently administered (or under evaluation) in the treatment of COVID-19.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research